mitomycin has been researched along with Conjunctival Diseases in 57 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Conjunctival Diseases: Diseases involving the CONJUNCTIVA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To find safer and more effective drugs than mitomycin C to prevent conjunctival fibrosis in a rabbit model." | 7.91 | Safety and efficacy of tacrolimus-coated silicone plates as an alternative to mitomycin C in a rabbit model of conjunctival fibrosis. ( Han, GS; Jung, HS; Kim, ES; Kim, JY; Suh, LH; Tchah, H; Yoon, SY, 2019) |
| "The purposes of this study were to investigate the effects of topically administrated Tacrolimus and Octreotide on modulation of postoperative scarring in experimental glaucoma filtration surgery and to compare the antifibrotic properties of these agents with mitomycin-C (MMC)." | 7.78 | Modulation of postoperative scarring with tacrolimus and octreotide in experimental glaucoma filtration surgery. ( Arslan, S; Aydemir, O; Dağlı, AF; Güler, M, 2012) |
| "To investigate whether topical administration of pirfenidone eye drops could be used to prevent postoperative scarring in a rabbit model of experimental glaucoma filtration surgery." | 7.77 | Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery. ( Lin, X; Sun, G; Wu, K; Yu, M; Zhong, H, 2011) |
| "To describe the incidence, characteristics, risk factors, and clinical outcome of limbal stem cell deficiency (LSCD) resulting from topical treatment with mitomycin C (MMC) for primary acquired melanosis (PAM) with atypia." | 7.76 | Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia. ( Frucht-Pery, J; Lichtinger, A; Pe'er, J; Solomon, A, 2010) |
| "The most effective dose of mitomycin C (MMC) in the treatment of primary acquired melanosis (PAM) with atypia of the conjunctiva and cornea has yet to be established." | 7.74 | Resolution of primary acquired melanosis with atypia after minimal mitomycin C treatment. ( Chappell, AJ; Chen, JY; Klebe, S; Mills, RA, 2007) |
| "To report our results of 12 consecutive patients with conjunctival primary acquired melanosis (PAM) with atypia who were treated by topical Mitomycin C (MMC)." | 7.73 | The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C. ( Frucht-Pery, J; Pe'er, J, 2005) |
| "To prospectively study the evolution of possible high risk features of conjunctival filtration blebs like avascularity, transconjunctival oozing (TCO), and leaks after mitomycin C (MMC) enhanced glaucoma surgery." | 7.73 | Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. ( Anand, N; Arora, S; Clowes, M, 2006) |
| "A case of primary acquired melanosis of the conjunctiva primarily treated with topical mitomycin chemotherapy is presented." | 7.72 | Topical mitomycin treatment for primary acquired melanosis of the conjunctiva. ( Brownstein, S; Dorey, MW; Jordan, DR; Yuen, VH, 2003) |
| "Comparison of fornix- and limbus-based conjunctival flaps with respect to cystic bleb-related complications of trabeculectomy with high-dose mitomycin C (MMC) in pediatric and young adult glaucoma." | 7.72 | Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. ( Bunce, C; Cordeiro, MF; Khaw, PT; Wells, AP, 2003) |
| "The rates of recurrence (5% to 9%) and complications in eyes that had undergone excision and mitomycin C instillation were less than those in eyes that had had excision only." | 5.28 | Postoperative instillation of mitomycin C in the treatment of recurrent pterygium. ( Hayasaka, S; Noda, S; Setogawa, T; Yamamoto, Y, 1989) |
| "To find safer and more effective drugs than mitomycin C to prevent conjunctival fibrosis in a rabbit model." | 3.91 | Safety and efficacy of tacrolimus-coated silicone plates as an alternative to mitomycin C in a rabbit model of conjunctival fibrosis. ( Han, GS; Jung, HS; Kim, ES; Kim, JY; Suh, LH; Tchah, H; Yoon, SY, 2019) |
| "Twelve filtering blebs of 8 patients were included: 4 cases of trabeculectomy without mitomycin C (MMC), 6 cases of trabeculectomy with MMC, and 2 cases of non-penetrating glaucoma surgery." | 3.80 | [Evaluation of conjunctival epithelium of filtering blebs by impression cytology]. ( Buetas, P; González, S; López, S; Matias-Guiu, X; Muniesa, MJ; Sánchez, C, 2014) |
| "The purposes of this study were to investigate the effects of topically administrated Tacrolimus and Octreotide on modulation of postoperative scarring in experimental glaucoma filtration surgery and to compare the antifibrotic properties of these agents with mitomycin-C (MMC)." | 3.78 | Modulation of postoperative scarring with tacrolimus and octreotide in experimental glaucoma filtration surgery. ( Arslan, S; Aydemir, O; Dağlı, AF; Güler, M, 2012) |
| "To investigate whether topical administration of pirfenidone eye drops could be used to prevent postoperative scarring in a rabbit model of experimental glaucoma filtration surgery." | 3.77 | Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery. ( Lin, X; Sun, G; Wu, K; Yu, M; Zhong, H, 2011) |
| "Two eyes of 2 patients status postfornix-based trabeculectomy with mitomycin C were found to have symptomatic circumferential blebs." | 3.76 | Application of handheld cautery for reduction of symptomatic circumferential trabeculectomy blebs. ( Albano, M; Schwartz, AL, 2010) |
| "To describe the incidence, characteristics, risk factors, and clinical outcome of limbal stem cell deficiency (LSCD) resulting from topical treatment with mitomycin C (MMC) for primary acquired melanosis (PAM) with atypia." | 3.76 | Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia. ( Frucht-Pery, J; Lichtinger, A; Pe'er, J; Solomon, A, 2010) |
| "The most effective dose of mitomycin C (MMC) in the treatment of primary acquired melanosis (PAM) with atypia of the conjunctiva and cornea has yet to be established." | 3.74 | Resolution of primary acquired melanosis with atypia after minimal mitomycin C treatment. ( Chappell, AJ; Chen, JY; Klebe, S; Mills, RA, 2007) |
| "To report our results of 12 consecutive patients with conjunctival primary acquired melanosis (PAM) with atypia who were treated by topical Mitomycin C (MMC)." | 3.73 | The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C. ( Frucht-Pery, J; Pe'er, J, 2005) |
| "To prospectively study the evolution of possible high risk features of conjunctival filtration blebs like avascularity, transconjunctival oozing (TCO), and leaks after mitomycin C (MMC) enhanced glaucoma surgery." | 3.73 | Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. ( Anand, N; Arora, S; Clowes, M, 2006) |
| "To investigate whether cultured autologous fibroblasts injected into the subconjunctival space of rabbit may be used as a new treatment modality for conjunctival and subconjunctival atrophy caused by mitomycin C (MMC)." | 3.73 | Injection of cultured autologous fibroblasts into the subconjunctival space of rabbits treated with mitomycin C. ( Hwang, JM; Kee, C, 2006) |
| "A case of primary acquired melanosis of the conjunctiva primarily treated with topical mitomycin chemotherapy is presented." | 3.72 | Topical mitomycin treatment for primary acquired melanosis of the conjunctiva. ( Brownstein, S; Dorey, MW; Jordan, DR; Yuen, VH, 2003) |
| "Comparison of fornix- and limbus-based conjunctival flaps with respect to cystic bleb-related complications of trabeculectomy with high-dose mitomycin C (MMC) in pediatric and young adult glaucoma." | 3.72 | Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. ( Bunce, C; Cordeiro, MF; Khaw, PT; Wells, AP, 2003) |
| "Mitomycin C trabeculectomy after dissection of conjunctival scar tissue may be useful for treating refractory glaucoma." | 3.70 | Mitomycin C trabeculectomy in eyes with cicatricial conjunctiva. ( Honda, Y; Honjo, M; Inatani, M; Tanihara, H, 1998) |
| "Amniotic membrane transplantation is a successful method when used alone in the reconstruction of early-stage conjunctival fornix obliteration and provides safe and effective results in advanced-stage fornix obliteration when performed in combination with topical 0." | 1.72 | Clinical Results of the Use of Amniotic Membrane Transplantation Alone or in Combination with Adjuvant Therapies in Conjunctival Fornix Reconstruction. ( Aslan Katırcıoğlu, Y; Kaderli, A; Örnek, F; Şingar Özdemir, E, 2022) |
| "Three procedures (6%) had intraoperative complications (2 iris prolapses, 1 subconjunctival hemorrhage)." | 1.43 | Medium-term Outcomes of Unsutured Scleral Flap Trabeculectomies. ( Ang, GS; Meagher, P; Wang, BZ, 2016) |
| "To report a rare case of atypical fibroxanthoma (AFX) of the bulbar conjunctiva, and to compare it with previously published cases of conjunctival AFX." | 1.42 | Atypical Fibroxanthoma of the Bulbar Conjunctiva. ( Daluvoy, MB; Ellington, KS; Proia, AD; Shieh, C, 2015) |
| "Each bleb was incised segmentally and the cut edges of the conjunctiva and Tenon capsule were sutured to the underlying sclera." | 1.33 | Surgical reduction of symptomatic, circumferential, filtering blebs. ( Anis, S; Liebmann, J; Ritch, R; Shihadeh, W, 2006) |
| "Surgical bleb reconstruction was indicated because of persistent or a recurring bleb leak despite conservative medical treatment and blood bleb injections in seven cases." | 1.31 | [Prognostic outcome of leaking filtering blebs reconstruction with rotational conjunctival flaps]. ( Ayed, T; Hamard, H; Hamard, P; Quesnot, S; Tazartes, M, 2001) |
| "The rates of recurrence (5% to 9%) and complications in eyes that had undergone excision and mitomycin C instillation were less than those in eyes that had had excision only." | 1.28 | Postoperative instillation of mitomycin C in the treatment of recurrent pterygium. ( Hayasaka, S; Noda, S; Setogawa, T; Yamamoto, Y, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.75) | 18.7374 |
| 1990's | 6 (10.53) | 18.2507 |
| 2000's | 24 (42.11) | 29.6817 |
| 2010's | 25 (43.86) | 24.3611 |
| 2020's | 1 (1.75) | 2.80 |
| Authors | Studies |
|---|---|
| Aslan Katırcıoğlu, Y | 1 |
| Kaderli, A | 1 |
| Şingar Özdemir, E | 1 |
| Örnek, F | 1 |
| Tran, AQ | 1 |
| Hoeppner, C | 1 |
| Venkateswaran, N | 1 |
| Choi, DS | 1 |
| Lee, WW | 1 |
| Del Noce, C | 1 |
| Vagge, A | 1 |
| Traverso, CE | 1 |
| Yoon, SY | 1 |
| Kim, ES | 1 |
| Han, GS | 1 |
| Suh, LH | 1 |
| Jung, HS | 1 |
| Tchah, H | 1 |
| Kim, JY | 1 |
| Lee, S | 2 |
| Go, J | 1 |
| Rhiu, S | 2 |
| Stulting, RD | 1 |
| Lee, M | 1 |
| Jang, S | 1 |
| Kim, HJ | 1 |
| Chung, ES | 1 |
| Kim, S | 1 |
| Seo, KY | 2 |
| Shin, HY | 1 |
| Kim, MS | 1 |
| Chung, SK | 2 |
| Zarbin, MA | 1 |
| Muniesa, MJ | 1 |
| González, S | 1 |
| Buetas, P | 1 |
| López, S | 1 |
| Sánchez, C | 1 |
| Matias-Guiu, X | 1 |
| Kojima, S | 1 |
| Sugiyama, T | 1 |
| Takai, S | 1 |
| Jin, D | 1 |
| Ueki, M | 1 |
| Oku, H | 1 |
| Tabata, Y | 1 |
| Ikeda, T | 1 |
| Sugimoto, Y | 1 |
| Mochizuki, H | 1 |
| Ohkubo, S | 1 |
| Higashide, T | 3 |
| Sugiyama, K | 3 |
| Kiuchi, Y | 1 |
| Shieh, C | 1 |
| Daluvoy, MB | 1 |
| Ellington, KS | 1 |
| Proia, AD | 1 |
| Wang, BZ | 1 |
| Ang, GS | 1 |
| Meagher, P | 1 |
| Vahdani, K | 1 |
| Thaller, VT | 1 |
| Albanese, G | 1 |
| Dean, AF | 1 |
| Kheirkhah, A | 2 |
| Blanco, G | 1 |
| Casas, V | 1 |
| Hayashida, Y | 1 |
| Raju, VK | 2 |
| Tseng, SC | 3 |
| Prata, TS | 1 |
| De Moraes, CG | 1 |
| Palmiero, PM | 1 |
| Tello, C | 1 |
| Liebmann, J | 2 |
| Ritch, R | 2 |
| Okuda, T | 2 |
| Fukuhira, Y | 2 |
| Sumi, Y | 1 |
| Shimomura, M | 2 |
| Boto-de-Los-Bueis, A | 1 |
| Díaz-Valle, D | 1 |
| Llorente-González, S | 1 |
| Pastora-Salvador, N | 1 |
| Patrón-Romero, M | 1 |
| Hernández-González, C | 1 |
| Ciancaglini, M | 1 |
| Carpineto, P | 1 |
| Agnifili, L | 1 |
| Nubile, M | 1 |
| Fasanella, V | 1 |
| Mattei, PA | 1 |
| Mastropasqua, L | 1 |
| Elner, VM | 1 |
| Newman-Casey, PA | 1 |
| Patil, AJ | 1 |
| Flint, A | 1 |
| Biswas, J | 1 |
| Moroi, SE | 1 |
| Pushparaj, V | 1 |
| Edward, DP | 1 |
| Suominen, S | 1 |
| Harju, M | 1 |
| Ihanamäki, T | 1 |
| Vesti, E | 1 |
| Schwartz, AL | 1 |
| Albano, M | 1 |
| Lichtinger, A | 1 |
| Pe'er, J | 3 |
| Frucht-Pery, J | 3 |
| Solomon, A | 1 |
| Zhong, H | 1 |
| Sun, G | 1 |
| Lin, X | 1 |
| Wu, K | 1 |
| Yu, M | 1 |
| Shim, J | 1 |
| Kim, EK | 1 |
| Lee, JS | 1 |
| Lee, JB | 1 |
| Arslan, S | 1 |
| Aydemir, O | 1 |
| Güler, M | 1 |
| Dağlı, AF | 1 |
| Rodríguez Feijoo, D | 1 |
| Romero Moreno, I | 1 |
| López Gutierrez, C | 1 |
| Usabiaga Usandizaga, M | 1 |
| Cisneros Carpio, M | 1 |
| Amias Gorostiza, A | 1 |
| Alberdi Alberdi, J | 1 |
| Kaneko, H | 1 |
| Ghaffari, R | 1 |
| Kaghazkanani, R | 1 |
| Hashemi, H | 1 |
| Behrouz, MJ | 1 |
| Irvine, F | 1 |
| Kumarasamy, M | 1 |
| Kemp, E | 1 |
| Roberts, F | 1 |
| Yang, PT | 1 |
| Tucker, NA | 1 |
| Rootman, DB | 1 |
| Rootman, DS | 1 |
| McGowan, H | 1 |
| Chan, CC | 1 |
| Tsakalaki, V | 1 |
| Halkia, A | 1 |
| Haniotis, V | 1 |
| Kafousi, M | 1 |
| Detorakis, ET | 1 |
| Rodríguez-Ares, T | 1 |
| Touriño, R | 1 |
| De Rojas, V | 1 |
| Becerra, E | 1 |
| Capeans, C | 1 |
| Yuen, VH | 1 |
| Jordan, DR | 1 |
| Brownstein, S | 1 |
| Dorey, MW | 1 |
| Wells, AP | 1 |
| Cordeiro, MF | 2 |
| Bunce, C | 1 |
| Khaw, PT | 2 |
| Inoue, T | 1 |
| Hirata, A | 1 |
| Kimura, A | 1 |
| Sonoda, S | 1 |
| Tanihara, H | 2 |
| Char, DH | 2 |
| Di Pascuale, MA | 1 |
| Liu, DT | 1 |
| Gao, YY | 1 |
| Baradaran-Rafii, A | 1 |
| Nava-Castañeda, A | 1 |
| Tovila-Canales, JL | 1 |
| Monroy-Serrano, MH | 1 |
| Tapia-Guerra, V | 1 |
| Tovilla-Y-Pomar, JL | 1 |
| Ordóñez-Blanco, A | 1 |
| Garnica-Hayashi, L | 1 |
| Garfias-Becerra, Y | 1 |
| Yao, YF | 1 |
| Qiu, WY | 1 |
| Zhang, YM | 1 |
| Krohn, J | 1 |
| Monge, OR | 1 |
| Anand, N | 1 |
| Arora, S | 1 |
| Clowes, M | 1 |
| Anis, S | 1 |
| Shihadeh, W | 1 |
| Hwang, JM | 1 |
| Kee, C | 1 |
| Chen, JY | 1 |
| Chappell, AJ | 1 |
| Klebe, S | 1 |
| Mills, RA | 1 |
| Anandajeya, WV | 1 |
| Corrêa, ZM | 1 |
| Augsburger, JJ | 1 |
| Secchi, AG | 1 |
| Tognon, MS | 1 |
| Honjo, M | 1 |
| Inatani, M | 1 |
| Honda, Y | 1 |
| Donnenfeld, ED | 1 |
| Perry, HD | 1 |
| Wallerstein, A | 1 |
| Caronia, RM | 1 |
| Kanellopoulos, AJ | 1 |
| Sforza, PD | 1 |
| D'Aversa, G | 1 |
| Leen, MM | 1 |
| Takahashi, Y | 1 |
| Li, Y | 1 |
| Stewart, JF | 1 |
| Chen, PP | 1 |
| Mills, RP | 1 |
| Reichel, MB | 1 |
| Gay, JA | 1 |
| D'Esposita, F | 1 |
| Alexander, RA | 1 |
| Sihota, R | 1 |
| Dada, T | 1 |
| Gupta, SD | 1 |
| Sharma, S | 1 |
| Arora, R | 1 |
| Agarwal, HC | 1 |
| Hamard, P | 1 |
| Tazartes, M | 1 |
| Ayed, T | 1 |
| Quesnot, S | 1 |
| Hamard, H | 1 |
| DeBry, PW | 1 |
| Perkins, TW | 1 |
| Heatley, G | 1 |
| Kaufman, P | 1 |
| Brumback, LC | 1 |
| Hayasaka, S | 1 |
| Noda, S | 1 |
| Yamamoto, Y | 1 |
| Setogawa, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Efficacy and Safety of Minimally Invasive Glaucoma Surgery on Chinese Primary Angle Closure Glaucoma[NCT02964676] | 246 participants (Anticipated) | Interventional | 2017-01-31 | Not yet recruiting | |||
| [NCT02665884] | 40 participants (Anticipated) | Observational | 2016-02-29 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for mitomycin and Conjunctival Diseases
| Article | Year |
|---|---|
Complications of cosmetic eye whitening.
Topics: Alkylating Agents; Conjunctival Diseases; Cosmetic Techniques; Humans; Mitomycin; Ophthalmic Solutio | 2017 |
3 trials available for mitomycin and Conjunctival Diseases
| Article | Year |
|---|---|
Intraocular Pressure Outcomes and Risk Factors for Failure in the Collaborative Bleb-Related Infection Incidence and Treatment Study.
Topics: Aged; Alkylating Agents; Antihypertensive Agents; Combined Modality Therapy; Conjunctival Diseases; | 2015 |
[Comparative study of amniotic membrane transplantation, with and without simultaneous application of mitomycin C in conjunctival fornix reconstruction].
Topics: Adult; Aged; Amnion; Cicatrix; Combined Modality Therapy; Conjunctiva; Conjunctival Diseases; Eye Bu | 2005 |
Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Conjunctiva; Conjunctival Diseases; Drug Evalu | 1999 |
53 other studies available for mitomycin and Conjunctival Diseases
| Article | Year |
|---|---|
Clinical Results of the Use of Amniotic Membrane Transplantation Alone or in Combination with Adjuvant Therapies in Conjunctival Fornix Reconstruction.
Topics: Adult; Amnion; Conjunctiva; Conjunctival Diseases; Eyelid Diseases; Female; Humans; Male; Middle Age | 2022 |
Bleb Needling with Mitomycin C as Adjunctive Therapy in Failing Blebs: A Retrospective Study.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Conjunctival Diseases; Female; Glaucoma, Open-Angle; Hum | 2019 |
Safety and efficacy of tacrolimus-coated silicone plates as an alternative to mitomycin C in a rabbit model of conjunctival fibrosis.
Topics: Animals; Conjunctiva; Conjunctival Diseases; Cornea; Disease Models, Animal; Fibroblasts; Fibrosis; | 2019 |
Cosmetic regional conjunctivectomy with postoperative mitomycin C application with or without bevacizumab injection.
Topics: Administration, Topical; Adult; Aged; Alkylating Agents; Angiogenesis Inhibitors; Antibodies, Monocl | 2013 |
The development of scleromalacia after regional conjunctivectomy with the postoperative application of mitomycin C as an adjuvant therapy.
Topics: Adult; Antibiotics, Antineoplastic; Conjunctival Diseases; Female; Humans; Mitomycin; Postoperative | 2013 |
Combination therapy to reduce conjunctival scarring after glaucoma surgery.
Topics: Alkylating Agents; Apoptosis; Calcium Channel Blockers; Cicatrix; Conjunctival Diseases; Cyclosporin | 2013 |
[Evaluation of conjunctival epithelium of filtering blebs by impression cytology].
Topics: Aged; Aged, 80 and over; Aqueous Humor; Blister; Conjunctival Diseases; Conjunctivitis; Cytological | 2014 |
Effects of Gelatin Hydrogel Loading Mitomycin C on Conjunctival Scarring in a Canine Filtration Surgery Model.
Topics: Administration, Topical; Animals; Cicatrix; Conjunctiva; Conjunctival Diseases; Disease Models, Anim | 2015 |
Atypical Fibroxanthoma of the Bulbar Conjunctiva.
Topics: Adult; Alkylating Agents; Combined Modality Therapy; Conjunctival Diseases; Cryotherapy; Female; Hum | 2015 |
Medium-term Outcomes of Unsutured Scleral Flap Trabeculectomies.
Topics: Adult; Aged; Aged, 80 and over; Conjunctival Diseases; Female; Glaucoma; Glaucoma, Open-Angle; Human | 2016 |
Periocular Amyloidosis Manifesting as Pseudopemphigoid Treated With Mitomycin C.
Topics: Alkylating Agents; Amyloidosis; Conjunctival Diseases; Eyelid Diseases; Female; Humans; Middle Aged; | 2017 |
Surgical strategies for fornix reconstruction based on symblepharon severity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Amnion; Child; Child, Preschool; Comb | 2008 |
Slit-lamp-adapted optical coherence tomography for assessment of an overhanging filtering bleb.
Topics: Aged; Alkylating Agents; Blister; Combined Modality Therapy; Conjunctival Diseases; Diagnostic Techn | 2010 |
A thin honeycomb-patterned film as an adhesion barrier in an animal model of glaucoma filtration surgery.
Topics: Absorbable Implants; Animals; Blister; Conjunctival Diseases; Disease Models, Animal; Filtering Surg | 2009 |
[Post-traumatic striate melanokeratosis in a Caucasian woman].
Topics: Conjunctival Diseases; Corneal Diseases; Corneal Ulcer; Eye Color; Female; Fluorometholone; Humans; | 2009 |
Conjunctival characteristics in primary open-angle glaucoma and modifications induced by trabeculectomy with mitomycin C: an in vivo confocal microscopy study.
Topics: Aged; Case-Control Studies; Conjunctiva; Conjunctival Diseases; Female; Glaucoma, Open-Angle; Humans | 2009 |
Aberrant wound-healing response in mitomycin C-treated leaking blebs: a histopathologic study.
Topics: Antibiotics, Antineoplastic; Conjunctival Diseases; Female; Fibroblasts; Fibrosis; Glaucoma; Humans; | 2009 |
The effect of deep sclerectomy on intraocular pressure of normal-tension glaucoma patients: 1-year results.
Topics: Absorbable Implants; Aged; Anterior Chamber; Collagen; Conjunctival Diseases; Female; Follow-Up Stud | 2010 |
Application of handheld cautery for reduction of symptomatic circumferential trabeculectomy blebs.
Topics: Aged; Ambulatory Surgical Procedures; Blister; Conjunctival Diseases; Electrocoagulation; Female; Gl | 2010 |
Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia.
Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Cell Count; Conjunctival Diseases | 2010 |
Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery.
Topics: Actins; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Movement; Ce | 2011 |
Complications of cosmetic wide conjunctivectomy combined with postsurgical mitomycin C application.
Topics: Adult; Astringents; Conjunctiva; Conjunctival Diseases; Female; Humans; Male; Middle Aged; Mitomycin | 2012 |
Modulation of postoperative scarring with tacrolimus and octreotide in experimental glaucoma filtration surgery.
Topics: Administration, Topical; Alkylating Agents; Animals; Cicatrix; Conjunctival Diseases; Disease Models | 2012 |
[Conjunctival keratoacanthoma: diagnosis, treatment and monitoring by conjunctival impression cytology].
Topics: Adult; Carcinoma, Squamous Cell; Combined Modality Therapy; Conjunctival Diseases; Conjunctival Neop | 2012 |
Suppression of avascular bleb formation by a thin biodegradable film in a rabbit filtration surgery with mitomycin C.
Topics: Absorbable Implants; Alkylating Agents; Animals; Biocompatible Materials; Conjunctival Diseases; Dis | 2012 |
A combined approach of amniotic membrane and oral mucosa transplantation for fornix reconstruction in severe symblepharon.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alkylating Agents; Amnion; Child; Child, Preschool; Conj | 2013 |
Progression of primary acquired melanosis with atypia during pregnancy.
Topics: Administration, Topical; Adult; Antibiotics, Antineoplastic; Conjunctival Diseases; Disease Progress | 2012 |
Pagetoid spread of sebaceous cell carcinoma to the cornea.
Topics: Adenocarcinoma, Sebaceous; Administration, Topical; Antibiotics, Antineoplastic; Biopsy; Conjunctiva | 2012 |
Conjunctival seborrheic keratosis manifesting as squamous carcinoma.
Topics: Alkylating Agents; Carcinoma, Squamous Cell; Conjunctival Diseases; Conjunctival Neoplasms; Diagnosi | 2013 |
Topical mitomycin C in the treatment of pigmented conjunctival lesions.
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Conjunctival Diseases; Female; Humans; M | 2003 |
Topical mitomycin treatment for primary acquired melanosis of the conjunctiva.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Conjunctival Diseases; Female; Humans; Melanos | 2003 |
Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C.
Topics: Adult; Antibiotics, Antineoplastic; Child; Combined Modality Therapy; Conjunctival Diseases; Cysts; | 2003 |
Mitomycin C trabeculectomy in an eye with cicatricial conjunctiva following amniotic membrane transplantation.
Topics: Adult; Amnion; Antibiotics, Antineoplastic; Biological Dressings; Cicatrix; Conjunctival Diseases; G | 2003 |
The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C.
Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Conjunctival Diseases; Female; Fo | 2005 |
Mitomycin for pigmented conjunctival lesions.
Topics: Antibiotics, Antineoplastic; Conjunctival Diseases; Humans; Melanosis; Mitomycin | 2005 |
Intraoperative mitomycin C and amniotic membrane transplantation for fornix reconstruction in severe cicatricial ocular surface diseases.
Topics: Adolescent; Adult; Aged; Amnion; Antibiotics, Antineoplastic; Child; Child, Preschool; Cicatrix; Com | 2005 |
Mitomycin C, amniotic membrane transplantation and limbal conjunctival autograft for treating multirecurrent pterygia with symblepharon and motility restriction.
Topics: Adult; Alkylating Agents; Amnion; Cell Transplantation; Combined Modality Therapy; Conjunctiva; Conj | 2006 |
[Conjunctival primary acquired melanosis].
Topics: Aged; Antibiotics, Antineoplastic; Conjunctival Diseases; Conjunctival Neoplasms; Cryotherapy; Diagn | 2005 |
Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks.
Topics: Aged; Blister; Conjunctiva; Conjunctival Diseases; Female; Fluorouracil; Glaucoma; Humans; Intraocul | 2006 |
Surgical reduction of symptomatic, circumferential, filtering blebs.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Blister; Combined Modality Therapy; Conjunctiv | 2006 |
Injection of cultured autologous fibroblasts into the subconjunctival space of rabbits treated with mitomycin C.
Topics: Animals; Antibiotics, Antineoplastic; Atrophy; Cells, Cultured; Conjunctiva; Conjunctival Diseases; | 2006 |
Complications of management in primary acquired melanosis with atypia.
Topics: Combined Modality Therapy; Conjunctival Diseases; Cryosurgery; Female; Humans; Melanosis; Middle Age | 2007 |
Resolution of primary acquired melanosis with atypia after minimal mitomycin C treatment.
Topics: Aged; Alkylating Agents; Conjunctiva; Conjunctival Diseases; Cornea; Drug Administration Schedule; F | 2007 |
Primary acquired melanosis with atypia treated with mitomycin C.
Topics: Alkylating Agents; Conjunctival Diseases; Conjunctival Neoplasms; Cryosurgery; Humans; Male; Melanom | 2009 |
Use of mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Biopsy; Conjunctiva; Conjunctival Diseases; Fe | 1996 |
Intraoperative mitomycin C in the treatment of cicatricial obliterations of conjunctival fornices.
Topics: Administration, Topical; Conjunctiva; Conjunctival Diseases; Follow-Up Studies; Humans; Intraoperati | 1996 |
Mitomycin C trabeculectomy in eyes with cicatricial conjunctiva.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Cicatrix; Conjunctival Diseases; Follow-Up S | 1998 |
Mitotic effect of autologous blood injection and diode laser bleb revision on rabbit filtration blebs.
Topics: Animals; Blood Transfusion, Autologous; Bromodeoxyuridine; Cell Count; Cell Division; Conjunctival D | 1999 |
Transforming growth factor-beta1, -beta2, and -beta3 in vivo: effects on normal and mitomycin C-modulated conjunctival scarring.
Topics: Animals; Cicatrix; Collagen; Conjunctiva; Conjunctival Diseases; Elastic Tissue; Fluorescent Antibod | 1999 |
Conjunctival dysfunction and mitomycin C-induced hypotony.
Topics: Adolescent; Antibiotics, Antineoplastic; Aqueous Humor; Combined Modality Therapy; Conjunctival Dise | 2000 |
[Prognostic outcome of leaking filtering blebs reconstruction with rotational conjunctival flaps].
Topics: Adult; Aged; Antimetabolites; Blister; Combined Modality Therapy; Conjunctival Diseases; Female; Flu | 2001 |
Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctival Diseases; Cross-Linking Reagents; En | 2002 |
Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctival Diseases; Cross-Linking Reagents; En | 2002 |
Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctival Diseases; Cross-Linking Reagents; En | 2002 |
Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Conjunctival Diseases; Cross-Linking Reagents; En | 2002 |
Postoperative instillation of mitomycin C in the treatment of recurrent pterygium.
Topics: Conjunctival Diseases; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Mitomycin; Mi | 1989 |